Download the UK Life Sciences Innovation Signals Report
The UK life sciences sector continues to attract investment, strengthen research capabilities and advance scientific innovation. The key question facing the market is no longer whether innovation is being created. It is whether innovation can be converted into commercial growth, healthcare adoption and measurable patient impact.
PIA Commercial are pleased to confirm the launch of our new website
As One Nucleus members we work closely with life science companies in the UK and overseas to establish the insurance protection they require, and meets those needs
Please have a look at the website which details how we can help you, and feel free to contact us by telephone , email, or via the website
Kind regards
The Earlham Institute has been awarded funding by the Gordon and Betty Moore Foundation to develop Protist Omics at Scale, a three-year international methods-development programme run in partnership with the Scottish Association for Marine Science, home of the Culture Collection of Algae and Protozoa, and the Bigelow Laboratory for Ocean Sciences.
Cambridge, UK, 28 July 2026 - One Nucleus expands its portfolio of member benefits through o2h co-discovery bringing discounted exclusive access for eligible One Nucleus members to specialist in-vitro ADME and DMPK services designed to support early-stage drug discovery.
Join Cambridge Network to welcome Howes Percival as our speakers to explain how data protection law is changing and what you need to know now to comply.
Data Protection law is constantly evolving. The Data (Use and Access) Act 2025 (DUAA), which amends the UK GDPR and Data Protection Act 2018, implemented a number of changes during the early part of 2026 with the last provisions taking effect from 19 June. It introduced some new key changes for UK organizations.
Pioneer Group and Oxford Properties have announced that Syncona Investment Management Ltd (SIML), a leading life science investment manager, is moving into Victoria House, a leading hub for life sciences in London.
Developed by Pioneer Group and Oxford Properties, Victoria House in Bloomsbury, London continues to build one of London’s most inspiring life science communities, where an ever-growing number of pioneering organisations are driving innovation across science, biopharmaceuticals, gene therapies, synthetic biology and AI.
TBI is a leading cause of death and disability, costs the UK economy over £10 billion, and the global economy over $500 billion, annually. Outcomes from TBI are poor – even with “mild” TBI, 30% of patients show incomplete recovery at six months post-injury. The scope for improvement (and potential market opportunity) is substantial. While many past trials have failed, the substantial new knowledge provides a timely opportunity to address this issue.
The One Nucleus Awards has been integrated into the Genesis Conference, to recognise outstanding achievements across our ecosystem. All shortlisted companies will receive a free delegate pass and will be invited to pitch at the company showcase, plus having the opportunity to network with over 400 delegates.
Deadline Approaching: Entries close on 17 September, enter here with our easy entry form.
Background
The Food and Nutrition National Bioscience Research Infrastructure (FN-NBRI) is the leading national provider of new and continuously updated data, knowledge and tools relating to food composition, intake and food systems for use by different end-users including academia, industry, healthcare, government, consumers.
Are you interested in studying metagenomic derived protein families and developing methods to interrogate vast collections of proteins, to determine pockets of interesting novel families? Metagenomics is transforming our understanding of the microbial world by uncovering enormous numbers of novel proteins. MGnify, one of the largest metagenomics resources, contains ~6 billion unique protein sequences. At the same time, artificial intelligence (AI) methods like AlphaFold and ESMfold can accurately predict protein structures directly from sequence.